Claudia Vegetti
Via Amadeo 42
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Journal: Oncogene
Published: January 30, 2019
NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Journal: Oncogene
Published: July 20, 2015
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.
Journal: Cell death & disease
Published: June 03, 2014
NFATc2 is a potential therapeutic target in human melanoma.
Journal: The Journal of investigative dermatology
Published: June 22, 2012
AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Journal: Melanoma research
Published: May 17, 2012
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026